Bilirubin, the gold within

Circulation

Volumn 126, Issue 22, 2012, Pages 2547-2549

  Seppen, Jurgen ^a   Bosma, Piter ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

bilirubin risk factors; biliverdin reductase; Editorials; heme oxygenase

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; GLUCURONOSYLTRANSFERASE 1A1; HEME; HEME OXYGENASE 1; IRON; LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); ENZYME ACTIVITY; ENZYME POLYMORPHISM; GILBERT DISEASE; GLUCURONIDATION; HEART DISEASE; HEART INFARCTION; HUMAN; LIPID OXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

BILIRUBIN; CORONARY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; STROKE;

EID: 84870242831     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.147082     Document Type: Review

References (19)

1. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008;60:79-127.
2. Fang LS, Bada JL. The blue-green blood plasma of marine fish. Comp Biochem Physiol B. 1990;97:37-45.
3. McDonagh AF, Palma LA, Schmid R. Reduction of biliverdin and placental transfer of bilirubin and biliverdin in the pregnant guinea pig. Biochem J. 1981;194:273-282.
4. Nytofte NS, Serrano MA, Monte MJ, Gonzalez-Sanchez E, Tumer Z, Ladefoged K, Briz O, Marin JJ. A homozygous nonsense mutation (c. 214C-A) in the biliverdin reductase gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis. J Med Genet. 2011;48:219-225.
5. Strassburg CP. Pharmacogenetics of Gilbert's syndrome. Pharmacogenomics. 2008;9:703-715.
6. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de BA, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333:1171-1175.
7. Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet. 1995;345:958-959.
8. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev. 1999;31:817-899.
9. Horsfall LJ, Nazareth I, Petersen I. Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation. 2012; 126:2556-2564.
10. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043-1046.
11. Chen AF, Chen DD, Daiber A, Faraci FM, Li H, Rembold CM, Laher I. Free radical biology of the cardiovascular system. Clin Sci (Lond). 2012; 123:73-91.
12. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, Chau LY. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2001;104:1519-1525.
13. Wu BJ, Chen K, Barter PJ, Rye KA. Niacin inhibits vascular inflammation via the induction of heme oxygenase-1. Circulation. 2012;125: 150-158.
14. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med. 2004;37:1097-1104.
15. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99: 16093-16098.
16. Maghzal GJ, Leck MC, Collinson E, Li C, Stocker R. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. J Biol Chem. 2009;284:29251-2959.
17. Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem. 2010;56:1535-1543.
18. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation. 2006;114:1476-1481.
19. Kunii H, Ishikawa K, Yamaguchi T, Komatsu N, Ichihara T, Maruyama Y. Bilirubin and its oxidative metabolite biopyrrins in patients with acute myocardial infarction. Fukushima J Med Sci. 2009;55:39-51.